Tag: lab test

Northwell Health Lab Team Leverages Data to Add Value

CEO SUMMARY: Today, insurers get risk-adjusted payments for treating patients who have high-cost health conditions and they make risk-adjusted payments to physicians, hospitals, and other providers. At Northwell Health, the clinical lab saw the opportunity to leverage lab test data with other clinical and demographic data to identify patients who were undiagnosed or whose conditions were

View Article

Dr. Papanicolaou Honored by Google Doodle on May 13

Pathologists and medical laboratory professionals the world over had a surprise on May 13 if they used Google for an Internet search. The doodle on the Google search home page honored pathologist Dr. Georgios Papanicolaou, who developed the Pap smear test used to screen for cervical cancer.

Papanicolaou was born in 1883 in Greece. He studied medicine in Greece and

View Article

TriCore Forges Ahead to Help Payers Manage Population Health

CEO SUMMARY: To develop new sources of revenue to offset declining fee-for-service payments, TriCore Reference Labs is collaborating with health insurers in novel ways to improve patient outcomes and lower healthcare costs. To achieve this, TriCore brings together data from lab tests, EHRs, patient demographics,  and geography. Analytical tools allow it to assess population health

View Article

PAMA Price Cuts Now Delivering One-Two Punch to Labs’ Revenue

WHEN DISCUSSING THEIR EARNINGS with Wall Street analysts in February, executives from both Laboratory Corporation of America (LabCorp) and Quest Diagnostics explained that the lab test price cuts from the Protecting Access to Medicare Act of 2014 (PAMA) were not only reducing revenue, but that many state Medicaid plans are following Medicare’s lead and cutting their

View Article

ACLA: NCCI Guidelines Are a ‘Step Backwards’

CEO SUMMARY: In a letter to the National Correct Coding Initiative, the American Clinical Laboratory Association (ACLA) raised significant concerns about new language in the policy manuals for Medicare and Medicaid. ACLA said the new NCCI guidelines for molecular and other tests requiring multiple steps for one specimen reduce transparency, increase the administrative burden on

View Article